Table I.
Morphologies of cutaneous booster reactions to COVID-19 vaccines reported to the American Academy of Dermatology/International League of Dermatologic Societies registry
| Number of total booster reactions, regardless of whether patients reacted to prior vaccine doses (Total individuals = 36, total number of distinct reactions = 93) |
Subset analysis: number of booster reactions, limited to patients who only reacted to the booster dose and not to prior vaccine doses (Total individuals = 26, total number of distinct reactions = 71) |
|||||||
|---|---|---|---|---|---|---|---|---|
| Morphology∗ | Total |
Moderna |
Pfizer |
Total |
||||
| n | % of total reactions | n | % of total reactions | n | % of total reactions | n | % of total reactions (restricted to individuals who only reacted to the booster dose) | |
| Urticaria | 14 | 15.1 | 10 | 10.8 | 2 | 2.2 | 12 | 16.9 |
| Localized swelling | 11 | 11.8 | 7 | 7.5 | 2 | 2.2 | 9 | 12.7 |
| Localized redness | 13 | 14.0 | 9 | 9.7 | 2 | 2.2 | 11 | 15.5 |
| Localized pain | 11 | 11.8 | 7 | 7.5 | 2 | 2.2 | 9 | 12.7 |
| Pruritus | 10 | 10.8 | 8 | 8.6 | 2 | 2.2 | 7 | 9.9 |
| Delayed hypersensitivity | 9 | 9.7 | 8 | 8.6 | 1 | 1.1 | 6 | 8.5 |
| Morbilliform | 3 | 3.2 | 1 | 1.1 | 2 | 2.2 | 2 | 2.8 |
| Vesicular | 3 | 3.2 | 2 | 2.2 | 1 | 1.1 | 2 | 2.8 |
| Erythromelalgia | 3 | 3.2 | 3 | 3.2 | 0 | 0.0 | 2 | 2.8 |
| Contact dermatitis | 2 | 2.2 | 1 | 1.1 | 1 | 1.1 | 1 | 1.1 |
| Angioedema | 2 | 2.2 | 1 | 1.1 | 1 | 1.1 | 2 | 2.8 |
| Pernio/chilblains | 1 | 1.1 | 0 | 0.0 | 1 | 1.1 | 0 | 0.0 |
| Livedo reticularis | 1 | 1.1 | 1 | 1.1 | 0 | 0.0 | 1 | 1.1 |
| Erythema multiforme | 1 | 1.1 | 1 | 1.1 | 0 | 0.0 | 1 | 1.1 |
| Pityriasis rosea | 1 | 1.1 | 0 | 0.0 | 1 | 1.1 | 1 | 1.1 |
| Flareup of an existing condition | 1 | 1.1 | 1 | 1.1 | 0 | 0.0 | 0 | 0.0 |
| Other | 7 | 7.5 | 3 | 3.2 | 2 | 2.2 | 5 | 7.0 |
∗
Listed as the number of reactions. Individual person may have >1 reaction.